Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase-Reference-Cited by-同舟云学术

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Published:2000-07 Issue:3 Volume:25 Page:302-305
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Shimura Hideki,Hattori Nobutaka,Kubo Shin-ichiro,Mizuno Yoshikuni,Asakawa Shuichi,Minoshima Shinsei,Shimizu Nobuyoshi,Iwai Kazuhiro,Chiba Tomoki,Tanaka Keiji,Suzuki Toshiaki

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0700_302.pdf

Reference30 articles.

1. Mizuno, Y., Hattori, N. & Matsumine, H. Neurochemical and neurogenetic correlates of Parkinson's disease. J. Neurochem. 71, 893–902 (1998).

2. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608 (1998).

3. Mayer, R.J., Landon, M. & Lowe, J. Ubiquitin and the molecular pathology of human disease. in Ubiquitin and the Biology of the Cell. (eds Peters, J.-M., Harris, J.R. & Finley, D.) 429–462 (Plenum, New York, 1998).

4. Alves-Rodrigues, A., Gregori, L. & Figueiredo-Pereira, M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21, 516–520 (1998).

5. Floyd, J.A. & Hamilton, B.A. Intranuclear inclusions and the ubiquitin-proteasome pathway: digestion of a red herring? Neuron 24, 765–766 (1999).

Cited by 1734 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interplay between mitophagy and mitochondrial ROS in acute lung injury;Mitochondrion;2024-09

2. Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease;Cellular and Molecular Neurobiology;2024-07-03

3. Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer’s Disease Models;Journal of Alzheimer's Disease;2024-06-25

4. Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease;Pharmaceuticals;2024-06-14

5. Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease;Metabolic Brain Disease;2024-06-05